(504) 309-4948
English Translate into French Translate into German Translate into Spanish Translate into Italian Translate into Japanese Translate into Hindi Translate into Korean Translate into Dutch Translate into Hebrew Translate into Swedish Translate into Chinese (Simplified) Translate into Russian

Giving people back their lives!

HBOT for Autism

Interview with Dr. Paul Harch: The Application of Hyperbaric Oxygen Therapy in Autism and Other Chronic Neurological Conditions

visit www.autismone.orgInterview with Dr. Paul Harch:
The application of hyperbaric oxygen therapy in chronic neurological conditions

 

 

Paul G. Harch, MD and Teri Small

 

As hyperbaric oxygen therapy (HBOT) moves closer to a standard of care for many deemed ‘hopeless’ diseases it still remains a controversial and misunderstood treatment. Currently there are thirteen medical conditions approved for treatment with HBOT. But over twenty-two years of experience has shown Dr. Paul Harch astounding medical benefits when applied to diseases like Cerebral Palsy Autism, Stroke, Traumatic Brain Injury, and many others. This interview explores the science behind these applications. 

Teri Small, from AutismOne Radio, and Dr. Harch talk about HBOT defined as a pharmaceutical and its pharmacologic effects in the application of HBOT to neurology, including autism. 

Traumatic Brain Injury Treated with Low Pressure Hyperbaric Oxygen Therapy and SPECT Scans Show Progressive Medical Improvement

The brain injury program is a direct outgrowth of the extensive experience of Dr. Harch treating chronically brain injured patients, the independent 22 year clinical Hyperbaric Oxygen Therapy experience of Dr. Harch's practice group (Van Meter and Associates) at the Jo Ellen Smith Medical Center Hyperbaric Medicine Unit, the published reports of Drs. Richard A Neubauer and S.F. Gottlieb, and the 27 year clinical experience with brain injury of Dr. R.A Neubauer in Florida. In the late 1980's while at the Jo Ellen Smith Hyperbaric Medicine Unit, Dr. Harch observed patients with cerebral decompression sickness and/or air embolism who responded to hyperbaric oxygen therapy long after treatment of inert gas bubbles had passed or with delayed treatment months to years after standard U.S. Navy treatments had achieved partial success. In addition, Dr. Harch observed patients with brain contusion or stroke who, months to years after their neurological injury, concomitantly experienced gratuitous neurological improvement during the course of Hyperbaric Oxygen treatment for one of the standard accepted indications.

Harch HBOT in Cerebral Palsy and Pediatric Neurology: A Scientific Perspective

This article will review the current literature and history of application of low pressure (low dosage) LPHBOT to pediatric neurology. The most rigorous study on this subject will be analyzed and its interpretation debated in terms of past and present scientific data and theoretical considerations. The major flaw in the study's conclusion is illustrated by pre and post HBOT SPECT brain imaging on two of the author's cerebral palsy patients and the author's 12-year-experiehce of HBOT treatment of Cerebral Palsy children. There is substantial scientific explanation and data to argue for reimbursement of HBOT in Cerebral Palsy.

HBOT in the Treatment of Chronic Traumatic Brain Injury:

 

HYPERBARIC OXYGEN THERAPY IN THE TREATMENT OF CHRONIC TRAUMATIC BRAIN INJURY:

FROM LOUISIANA BOXERS TO U.S. VETERANS, AN AMERICAN CHRONOLOGY

 

PAUL G. HARCH, M.D.
CLINICAL ASSOCIATE PROFESSOR
LSU SCHOOL OF MEDICINE, NEW ORLEANS

 

The application of hyperbaric oxygen therapy (HBOT) to chronic traumatic brain injury (TBI) can be traced to clinical practice and research in South Florida and New Orleans, Louisiana. It is well known that the practice of HBOT in chronic neurological conditions was pioneered by the late Dr. Richard Neubauer in the 1970s. Beginning with a serendipitous finding of gratuitous neurological improvement in two multiple sclerosis patients undergoing HBOT for chronic bone infections, Dr. Neubauer began applying HBOT to patients with other neurological conditions, primarily stroke. In 1994, he published his first case of HBOT treatment of chronic TBI in the Southern Medical Journal.

 




Chad Rovira Acute TBI treated with HBOT

Pages